Idorsia (OTCMKTS:IDRSF) Trading Down 7.4% – Time to Sell?

Idorsia Ltd (OTCMKTS:IDRSFGet Free Report)’s share price dropped 7.4% on Wednesday . The company traded as low as $1.00 and last traded at $1.00. Approximately 155 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 2,738 shares. The stock had previously closed at $1.08.

Idorsia Price Performance

The stock has a 50 day moving average of $2.09 and a two-hundred day moving average of $2.29.

About Idorsia

(Get Free Report)

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.

Further Reading

Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.